Aptitude Receives FDA 510(k) Clearance for Next-Generation Metrix COVID Test with 3x Sensitivity
Aptitude Medical Systems received FDA 510(k) clearance for its next-generation Metrix COVID test, which offers three times higher sensitivity and 30% faster results than its EUA predecessor, ahead of the December 2026 EUA termination deadline.
· San Francisco Chronicle, PR Newswire, Clinical Lab Products